Press release
US Interleukin Inhibitors Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
The US Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.0% over the forecast period (2021-2027). The key aspect that drives the growth of the US Interleukin Inhibitors market includes the rise in the prevalence of arthritis, asthma, eczema, inflammatory bowel disease (IBD), psoriasis, and others. According to the Institute for Health Metrics and Evaluation, the prevalence of psoriasis was 4.1 million in 2017 which increased to 4.2 million in 2019. The prevalence of inflammatory bowel disease (IBD) was more than 749,000 which increased to more than 762,000 in 2019.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-interleukin-inhibitors-market
Whereas, the prevalence of asthma was 32.6 million in 2017 which increased to 33.9 million in 2019. The rise in the prevalence of such diseases demands for advanced treatment options including interleukin inhibitors, which, in turn, drives the growth of the market. Further, the presence of the key market players operating in the market also drives the growth of the market in the country over the forecast period. Players such as Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, AstraZeneca Plc, and Sun Pharmaceutical Industries Ltd. among others contribute to the growth of the market across the country by adopting various growth strategies.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/us-interleukin-inhibitors-market
US Interleukin Inhibitors Market – Segmentation
By Product Type
• IL-1 Inhibitors
• IL-5 Inhibitors
• IL-6 Inhibitors
• IL-17 Inhibitors
• IL-23 Inhibitors
By Applications
• Arthritis
• Asthma
• Eczema
• Inflammatory Bowel Disease (IBD)
• Psoriasis
• Others
Company Profiles
• AbbVie, Inc.
• AstraZeneca Plc
• Bausch Health Co. Inc.
• Bristol–Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Merck KgaA
• Novartis AG
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-interleukin-inhibitors-market
Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Interleukin Inhibitors Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 here
News-ID: 2282208 • Views: …
More Releases from Orion Market Research
Textile Market Is Expected to Exhibit Significant Growth Over 2031 / Aditya Birl …
Textile Market is projected to grow at a CAGR of 4.8% during the forecast period. The textile sector is an ever-growing market with remarkable growth prospects almost all across the globe. Favourable demographics, increasing per capita income, and a shift in preference toward branded products to drive demand for textile, globally. Superior quality and advantageous trade policies are also estimated to play an imperative role and boost textile exports.
Growth in…
Stuffed Animal & Plush Toys Market Size, Share, Trends, Demand, Segments, Leadin …
The global stuffed animal & plush toys market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2024-2031). The offline distribution channel was the largest segment in the stuffed animal & plush toys market. Offline distribution channels include gift stores, toy stores, hypermarkets, specialty stores, and others. The availability of a wide range of products in these stores is the key growth-driving factor for the segment. Moreover,…
Specialty Paper Market Update Report 2024| Industry Trends, Demand, Leading Comp …
Specialty Paper Market is projected to grow at a CAGR of over 4% during the forecast period. The key factors that drive the growth of the market include the growth in the labelling and packaging industries. The majority of paper used in the packaging and labelling industry is specialty paper. The rise in disposable and changing lifestyles along with the increased demand for specialty papers in food service, packaging, and…
Plant Protein Hydrolysates Market Is Expected to Exhibit Significant Growth Over …
Plant Protein Hydrolysates Market is estimated to grow at a considerable CAGR of % during the forecast period. Protein hydrolysates are formed by the hydrolysis of protein. Factors such as the growing demand for plant-based in the sports industry to drive the growth of the global market. Increasing demand for the product as a for infant nutrition, and as a nutraceutical is expected to drive market growth. Additionally, the…
More Releases for Inhibitors
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Regist …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
Tumor Necrosis Factor Inhibitors Market & TNF Inhibitors Clinical Pipeline Outlo …
The search for the effective therapeutic approaches in the modulation of the TNF has been focus of the research efforts. Approximately 1 Million people in the worldwide either undergoing the treatment or have been treated with the TNF inhibitors which are available in the pharmaceutical market which surrounding the indications that include the rheumatoid arthritis, psoriatic arthritis, psoriasis and inflammatory bowel diseases.
The neutralization of the TNF signaling can be achieved…
